前往化源商城

品牌现货直购
供应商:我要出现这里


查看所有供应商和价格请点击:

128517-07-7生产厂家

128517-07-7价格

128517-07-7

128517-07-7结构式
128517-07-7结构式

化源商城直购

中文名 罗米地辛
英文名 romidepsin
中文别名 (1S,4S,7Z,10S,16E,21R)-7-亚乙基-4,21-二异丙基-2-氧杂-12,13-二硫杂-5,8,20,23-四氮杂双环[8.7.6]二十三烷-16-烯-3,6,9,19,22-五酮
抗生素 FR901228
FK228 罗米地辛
抑制剂Romidsin
罗米地辛抑制剂
罗米地辛, 一种有效的HDAC1和HDAC2抑制剂
罗米地辛 (FK228, DSIPTIDE)
化合物:Romidsin (FK228, dsiptide)
化合物:Romidsin (FK228, dsiptide)
ROMIDSIN,HDAC1和HDAC2抑制剂
2-氧杂-12,13-二硫杂-5,8,20,23-四氮杂双环[8.7.6]三十烷,环肽衍生物
HDAC1和HDAC2抑制剂(ROMIDSIN)
英文别名 FK 228; FR 901228; NSC 630176; DSIPTIDE;FK228
Romidsin D7Q: What is Romidsin D7 Q: What is the CAS Number of Romidsin D7 Q: What is the storage condition of Romidsin D7 Q: What e the applications of Romidsin D7
dsiptide
Romidsin a potent HDAC1 and HDAC2 inhibitor
(1S,4S,7Z,10S,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone
Romidsin Antibiotic FR
Chromadax
Romidsin
Antibiotic FR
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-Mercapto-4-htenoyl-D-valyl-D-cysteinyl],cyclic (3®
Romidepsin
Istodax
FK228, Dsiptide
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone //BP
istodax
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
GSI-001
FK-228
Romidsin (FK228, FR901228, Dsiptide, NSC630176)
GS-003
(1S,4S,7Z,10S,21R)-7-Ethylidene-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
Romidsin - Bio-X
GS-002
(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentaone
FK228 Romidsin FK-228
[S-(E)]-N-(3-Hydroxy-7-Mercapto-1-oxo-4- htenyl)-D-valyl-D-cysteinyl-(Z)-2,3-didehydro-2-aMinobutanoyl
Romidsin (FK228, Dsiptide, FR1228)
RoMidsin-d8
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-Mercapto-4-htenoyl-D-valyl-D-cysteinyl]-d8 Cyclic (35)-Disulfide
FK228 RoMidsin
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-Mercapto-4-htenoyl-D-valyl-D-cysteinyl] Cyclic (35)-Disulfide
(1S,4S,7Z,10S,16Z,21R)-7-Ethylidene-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
Romidixin
5)-disulfide
Romidisin
FK228
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone RoMidsin (FK228, Dsiptide)
RoMidsin/Dsiptide(FK-228, NSC-63017)
RoMidsin(FK228)
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18
Depsipeptide
Romidepsin (FK228,depsipeptide)
Romidsin, >=
RoMidsin (FK228 ,Dsiptide)
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,23-pentone
描述 Romidepsin 是一种有效的 HDAC1 和 HDAC2 抑制剂,IC50 值分别为 36 nM 和 47 nM。
相关类别
靶点

HDAC1:36 nM (IC50)

HDAC2:47 nM (IC50)

HDAC4:510 nM (IC50)

HDAC6:14000 nM (IC50)

体外研究 罗米地辛有效抑制HDAC1和HDAC2(IC50 = 36,47 nM,分别)。罗米地辛对HDAC4和HDAC6具有轻微抑制作用(IC50 = 510,14000nM)。罗米地辛诱导组蛋白乙酰化和p21表达,EC50为3.0 nM。由于redFK在HeLa细胞中的不稳定性,Romidepsin比redFK更强,EC50为11 nM [1]。 Romidepsin的效力是TSA的100倍,在抑制A549细胞增殖方面比丁酸盐强1,000,000倍。 Romidepsin导致有丝分裂停滞,HDIs治疗导致有丝分裂染色体分离缺陷[2]。罗米地辛抑制U-937,K562和CCRF-CEM细胞的生长,IC50值分别为5.92 nM,8.36 nM和6.95 nM [3]。
体内研究 在scid小鼠淋巴瘤模型中,罗米地辛治疗小鼠每周一次或两次比对照小鼠存活时间更长,中位生存时间分别为30.5(0.56 mg/kg)和33天(0.32 mg/kg)(相对于20天)控制小鼠)。值得注意的是,用罗米地辛治疗的12只小鼠中有2只(0.56mg/kg,每周一次或两次)在60天的观察期后存活。在用罗米地辛处理48小时后,U-937细胞的凋亡群体以时间依赖性方式增加至37.7%。此外,罗米地辛诱导G1和G2/M阻滞以及U-937细胞分化为CD11b(+)/ CD14(+)表型。在用罗米地辛处理24小时后,p21(WAF1/Cip1)和凝溶胶蛋白mRNA的表达分别增加至654倍和152倍。 Romidepsin在p21(WAF1/Cip1)启动子区域引起组蛋白乙酰化,包括Sp1结合位点[3]。
激酶实验 对于酶测定,将10μL[3H]乙酰基标记的组蛋白(25,000cpm /10μg)加入到90μL从过量表达HDAC1或HDAC2的293T细胞中提取的HDAC酶级分中,在增加浓度的罗米地辛存在下,和将混合物在37℃下温育15分钟。酶反应是线性的至少1小时。加入10μL浓HCl终止反应。用1mL乙酸乙酯萃取释放的[3H]乙酸,并将0.9mL溶剂层加入5mL含水计数闪烁液II水溶液中以测定放射性。 IC50值由至少三个独立的剂量 - 反应曲线确定。
细胞实验 将细胞在96孔板中暴露于各种浓度的罗米地辛72小时。向每个孔中加入20μL5mg/ mL MTT的PBS溶液4小时。除去培养基后,向各孔中加入170μLDMSO以溶解甲crystals晶体。测定540nm处的吸光度。另外,将细胞与台盼蓝一起孵育,并在血细胞计数器中计数蓝色(死亡)细胞和透明(活)细胞的数量。对于细胞周期分析,将细胞在含有0.05mg / mL碘化丙啶,1mM EDTA,0.1%Triton X-100和PBS中1mg / mL RNase A的碘化丙锭染色溶液中孵育30分钟。然后使悬浮液通过尼龙筛网过滤器并在Becton Dickinson FACScan上分析。
动物实验 简而言之,腹膜内注射150mg / kg环磷酰胺的雄性scidmice。所有注射环磷酰胺的小鼠仅在观察期内存活。环磷酰胺注射后24小时,用500μLPBS中的1×107U-937细胞腹膜内接种小鼠。在肿瘤细胞接种后24小时,用或不用FK228腹膜内处理小鼠,剂量范围为0.1至1mg / kg,每周一次或两次。对照小鼠每周两次用10%HCO60盐水处理。 6只和12只小鼠分别用于FK228处理组和对照组。观察期为细胞接种后60天,通过存活时间评估抗肿瘤效果,通过Peto检验分析其统计学显着性。
参考文献

[1]. Furumai R, et al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res. 2002 Sep 1;62(17):4916-21.

[2]. Blagosklonny MV, et al. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. Mol Cancer Ther. 2002 Sep;1(11):937-41.

[3]. Sasakawa Y, et al. Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo. Biochem Pharmacol. 2002 Oct 1;64(7):1079-90.

密度 1.2±0.1 g/cm3
沸点 942.8±65.0 °C at 760 mmHg
熔点 219-224°C
分子式 C24H36N4O6S2
分子量 540.696
闪点 524.0±34.3 °C
精确质量 540.207642
PSA 193.30000
LogP 0.95
蒸汽压 0.0±0.3 mmHg at 25°C
折射率 1.529
储存条件 Amber Vial, -20°C Freezer, Under Inert Atmosphere

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YV9399000
CHEMICAL NAME :
L-Valine, N-(3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-c ysteinyl-(Z)-2,3-dide hydro-2- aminobutanoyl-, ti-lactone, cyclic (1-2)-disulfide, (S-(E))-
CAS REGISTRY NUMBER :
128517-07-7
LAST UPDATED :
199610
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C24-H36-N4-O6-S2
MOLECULAR WEIGHT :
540.76

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
6400 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 47,301,1994
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 47,301,1994

危险品运输编码 NONH for all modes of transport
RTECS号 YV9399000
海关编码 29349990
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。